MedTrace Logo

Optimisation and Performance of Reduced Preparation CT Colography

NCT00212433 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-05-23

No results posted yet for this study

Summary

To ascertain which of four combinations of low residue diet, reduced laxative dose and oral contrast agent is best tolerated by patients and optimally prepares the colon prior ro CT colonography

Conditions

  • Patients With Potential Colorectal Neoplasia

Interventions

DRUG

Tagitol V, Lo So, Readi-Cat 2

Sponsors & Collaborators

  • St Mark's Foundation

    collaborator UNKNOWN

  • London North West Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Stuart Taylor, MD · St Mark's Hospital, North West London NHS Trust; & University College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2006-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00212433 on ClinicalTrials.gov